STOCK TITAN

Planned sale of 5,608 SOPH (NASDAQ: SOPH) shares disclosed

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

A holder of common stock has filed a Form 144 indicating an intent to sell 5,608 shares through Morgan Stanley Smith Barney on the NASDAQ, with an approximate sale date of 01/20/2026 and an aggregate market value of $30,563.60. These shares were acquired as restricted stock units from the issuer on 04/18/2024.

The notice also lists recent Rule 10b5-1 sales for Philippe Menu, including 5,000–5,006-share transactions on 01/12/2026 and 01/06/2026 and several smaller sales in late 2025, with disclosed gross proceeds for each trade. The filing notes that total common shares outstanding are 67,847,058 at the time of the planned sale.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the SOPH Form 144 filing disclose?

The Form 144 discloses a planned sale of 5,608 shares of common stock on the NASDAQ, with an aggregate market value of $30,563.60, to be executed through Morgan Stanley Smith Barney.

Who is associated with the planned SOPH share sale?

The filing lists Philippe Menu in connection with past Rule 10b5-1 sales of common stock and identifies common shares acquired from the issuer as restricted stock units.

How many SOPH shares were acquired and when?

The holder acquired 5,608 common shares as restricted stock units from the issuer on 04/18/2024, with the same amount shown as the planned sale quantity.

What recent 10b5-1 sales are reported for SOPH stock?

Recent 10b5-1 sales for Philippe Menu include trades on 01/12/2026 (5,000 shares for $25,622.50) and 01/06/2026 (5,006 shares for $23,885.13), plus several smaller sales in late 2025.

How many SOPH common shares are outstanding?

The filing states that there are 67,847,058 common shares outstanding at the time of the planned sale.

On which exchange will the SOPH shares be sold?

The planned 5,608-share sale of common stock is listed as occurring on the NASDAQ exchange.

Which broker is handling the planned SOPH share sale?

The filing identifies Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, New York, as the broker for the planned sale.
Sophia Genetics Sa

NASDAQ:SOPH

SOPH Rankings

SOPH Latest News

SOPH Latest SEC Filings

SOPH Stock Data

369.77M
63.48M
6.46%
48.2%
0.06%
Health Information Services
Healthcare
Link
Switzerland
Rolle